Deborah J. Mariottini
Associate
- NEW YORK Phone: 212-808-2914 Fax: 212-351-3401
Deborah Mariottini’s practice focuses on complex technology disputes, including patent litigation, PTAB proceedings, licensing disputes, and international arbitration proceedings. Her experience includes all phases of litigation, including preparing pleadings and contentions, managing discovery, taking and defending fact and expert depositions, drafting briefs, arguing issues at hearings, preparing and conducting trial examinations, and handling dispute resolution in cases involving medical devices, biotechnology, and computer networking technology. She has also represented pro bono clients before the United States District Court for the Southern District of New York and the Court of Appeals for Veterans Claims.
She was part of the team that represented biotech company Ravgen in two jury trials, against Laboratory Corporation of America and Natera. At the trials, Ms. Mariottini conducted the examinations of Ravgen’s clinical expert and technical expert on source code. The team achieved a victory in both cases, resulting in a judgment of over $272M against LabCorp plus a $100M enhancement for its willful infringement and $57M against Natera.
As part of her pro bono practice, Ms. Mariottini successfully obtained death and indemnity compensation benefits for a veterans’ widow after the Board of Veterans’ Appeals had denied the claim twice. After the first denial, the Court of Appeals of Veterans Claims voluntarily remanded the case, agreeing that the board had erred in its consideration of the claim. After the Board denied the claim a second time, despite a new letter from the veteran’s doctor to establish that his death was service connected, the Desmarais team appealed again. This Appeals Court then issued a rare reversal and granted the veteran’s widow benefits.
During law school, Ms. Mariottini was an editor for the Journal of Law and Technology, a law journal that publishes about intellectual property law, privacy law, and other issues at the intersection of law and technology. She completed extensive coursework in intellectual property, including a patent trial advocacy course which simulated a patent trial from complaint to verdict. She also worked with the Harvard Law Entrepreneurship Project to provide legal advice to entrepreneurs and startups and represented tenants of public and subsidized housing at administrative hearings through the Tenant Advocacy Project. Before law school, she taught high school mathematics through Blue Engine, an AmeriCorps program.
She was part of the team that represented biotech company Ravgen in two jury trials, against Laboratory Corporation of America and Natera. At the trials, Ms. Mariottini conducted the examinations of Ravgen’s clinical expert and technical expert on source code. The team achieved a victory in both cases, resulting in a judgment of over $272M against LabCorp plus a $100M enhancement for its willful infringement and $57M against Natera.
As part of her pro bono practice, Ms. Mariottini successfully obtained death and indemnity compensation benefits for a veterans’ widow after the Board of Veterans’ Appeals had denied the claim twice. After the first denial, the Court of Appeals of Veterans Claims voluntarily remanded the case, agreeing that the board had erred in its consideration of the claim. After the Board denied the claim a second time, despite a new letter from the veteran’s doctor to establish that his death was service connected, the Desmarais team appealed again. This Appeals Court then issued a rare reversal and granted the veteran’s widow benefits.
During law school, Ms. Mariottini was an editor for the Journal of Law and Technology, a law journal that publishes about intellectual property law, privacy law, and other issues at the intersection of law and technology. She completed extensive coursework in intellectual property, including a patent trial advocacy course which simulated a patent trial from complaint to verdict. She also worked with the Harvard Law Entrepreneurship Project to provide legal advice to entrepreneurs and startups and represented tenants of public and subsidized housing at administrative hearings through the Tenant Advocacy Project. Before law school, she taught high school mathematics through Blue Engine, an AmeriCorps program.
Prior Experience
- Summer Associate, Desmarais LLP, 2017, 2018
- Summer Associate, Paul, Weiss, Rifkind, Wharton & Garrison LLP, 2018
Courts
- United States Court of Appeals for the Federal Circuit
Other Distinctions
- Massachusetts Supreme Judicial Court Pro Bono Honor Roll (2017)
- Counsel for plaintiff in patent infringement litigations regarding noninvasive testing - Ravgen, Inc. v. Laboratory Corporation of America Holdings, 6:20-cv-00969 (W.D. Tex.); Ravgen, Inc. v. Natera, Inc. et al., 1:20-cv-00692 (W.D. Tex.); Ravgen, Inc. v. Quest Diagnostics Inc., 2:21-cv-09011 (C.D. Cal.); Ravgen Inc. v. Illumina Inc. and Verinata Health Inc., 2:20-cv-1734 (D. Del.); Ravgen Inc. v. Myriad Genetics, Inc. and Myriad Women’s Health, Inc., 2:20-01730 (D. Del.)
- Represented defendant Cisco against Orckit Corporation in a patent litigation in Eastern District of Texas
- Counsel for defendant Auris Health in a patent infringement district court action involving medical device technology
- Counsel for international biotechnology company in arbitration proceeding defending against claims regarding patent licensing dispute
- Counsel for research laboratory in a licensing dispute with a pharma company that achieved a favorable resolution without needing to litigate
- "Deal Ends Google Patent Case Soon After Start Of $22.5M Trial" - Law360, November 12, 2024
- “Desmarais LLP Secures $272.5M Jury Verdict in Prenatal Genetic Testing Patent Trial” – Ms. Mariottini was part of the Desmarais LLP team that won a $272.5 million jury verdict for Ravgen in a patent infringement trial in the Western District of Texas.
- "Desmarais LLP Secures $100M Enhanced Damages Ruling for Ravgen"
- "Desmarais LLP Wins $57M Jury Verdict for Ravgen in Prenatal Genetic Testing Patent Trial"
- Desmarais LLP Awarded “Law360 IP Practice Group of the Year’” – Ms. Mariottini was interviewed about the $272.5 million jury verdict on behalf of Ravgen against LabCorp and the firm’s training programs.
- "Desmarais LLP Wins Appellate Reversal for Veteran’s Widow in Pro Bono DIC Case"
- Desmarais LLP Defeats Labcorp’s Attempt to Undermine Ravgen’s Trial Victory
- Desmarais LLP Wins $57M Jury Verdict for Ravgen in Prenatal Genetic Testing Patent Trial
- Desmarais LLP Wins Appellate Reversal for Veteran’s Widow in Pro Bono DIC Case
- Desmarais LLP Secures $100M Enhanced Damages Ruling for Ravgen
- Desmarais LLP Defeats Final PTAB Challenge to Ravgen’s Genetic-Testing Patents
- Desmarais LLP Secures Patent Litigation Settlement for Ravgen
- Law360 IP Practice Group of the Year Award Highlights Desmarais LLP’s Trial Wins, Training Program
- Desmarais LLP Secures $272.5M Jury Verdict in Prenatal Genetic Testing Patent Trial
- NYIPLA Patent Litigation Committee Meeting: Creating A Winning Trial Team – April 19, 2023
EDUCATION
Harvard Law School, J.D., 2019, cum laude; Editor, Journal of Law and TechnologyBinghamton University, State University of New York, B.A., Political Science and Physics, 2015, magna cum laude; Sigma Pi Sigma, Physics Honor Society; George E. Moore Merit Minority Physics Scholarship